| Mar'20 | Mar'19 | Mar'18 | Mar'17 | |||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
192,560 | 222,607 | 116,832 | 43,500 | |||
General and administrative | ||||||
82,327 | 42,219 | 24,231 | 12,357 | |||
Operating Expenses | ||||||
274,887 | 264,826 | 141,063 | 55,857 | |||
Interest expense | ||||||
11,222 | 8,821 | 2,046 | 0 | |||
Changes in the fair value of the Takeda warrant liability | ||||||
- | - | - | 27,518 | |||
Loss on extinguishment of debt | ||||||
-4,900 | 0 | 0 | - | |||
Interest expense (related party) | ||||||
1,441 | 0 | 0 | - | |||
Interest income | ||||||
2,552 | 881 | 0 | 0 | |||
Other (income) expense, net | ||||||
1,621 | -309 | 67 | -139 | |||
Total loss before income taxes | ||||||
-288,228 | -273,075 | -143,042 | - | |||
Loss before income taxes | ||||||
- | - | - | -83,514 | |||
Income Tax Expense (Benefit) | ||||||
761 | 476 | 213 | -74 | |||
Net Income (Loss) Attributable to Parent | ||||||
-289,000 | -273,551 | -143,255 | -83,440 | |||
Net loss per common share — basic and diluted (in USD per share) | ||||||
-3.37 | -4.09 | -2.41 | -1.70 | |||
Weighted average common shares outstanding — basic and diluted (in shares) | ||||||
85,839 | 66,910 | 59,520 | 49,184 | |||